Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes

Biochemical and Biophysical Research Communications

Volumn 305, Issue 2, 2003, Pages 229-234

  Harmon, Anne W ^a   Patel, Yashomati M ^a  

^a IL   (United States)

Author keywords

Adipocytes; Akt; Diabetes; Flavonoid; Glucose uptake; Naringenin; Phosphoinositide 3 kinase

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; NARINGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CULTURE MEDIUM; DIETARY INTAKE; DISEASE EXACERBATION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; GLUCOSE TRANSPORT; GLUCOSE TRANSPORT SYSTEM; GRAPEFRUIT; INSULIN RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CITRUS X PARADISI;

EID: 0038706097     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00720-4     Document Type: Article

References (38)

1. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110:1996;41-48.
2. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37:1988;837-841.
3. Miksicek R.J. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 44:1993;37-43.
4. Le Bail J.C., Varnat F., Nicolas J.C., Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130:1998;209-216.
5. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
6. Hagiwara M., Inoue S., Tanaka T., Nunoki I., Ito M., Hidaka H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem. Pharmacol. 37:1988;2987-2992.
7. Beretz A., Anton R., Stoclet J.C. Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia. 34:1978;1054-1055.
8. Yamashita Y., Kawada S., Nakamo H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orbol. Biochem. Pharmacol. 39:1990;737-744.
9. Guengerich F.P., Kim D.H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 11:1990;2275-2279.
10. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 50:1995;1485-1493.
11. So F.V., Guthrie N., Chambers A.F., Moussa M., Carroll K.K. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer. 26:1996;167-181.
12. van Acker F.A., Schouten O., Haenen G.R., van der Vijgh W.J., Bast A. Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett. 473:2000;145-148.
13. Santos K.F., Oliveira T.T., Nagem T.J., Pinto A.S., Oliveira M.G. Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations. Pharmacol. Res. 40:1999;493-496.
14. Lee S.H., Park Y.B., Bae K.H., Bok S.H., Kwon Y.K., Lee E.S., Choi M.S. Cholesterol-lowering activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A: cholesterol acyltransferase in rats. Ann. Nutr. Metab. 43:1999;173-180.
15. Borradaile N.M., Carroll K.K., Kurowska E.M. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids. 34:1999;591-598.
16. Harmon A.W., Harp J.B. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J. Physiol. 280:2001;C807-C813.
17. Park J.B. Flavonoids are potential inhibitors of glucose uptake in U937 cells. Biochem. Biophys. Res. Commun. 260:1999;568-574.
18. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., Minnemann T., Shulman G.I., Kahn B.B. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409:2001;729-733.
19. Baumann C.A., Saltiel A.R. Spatial compartmentalization of signal transduction in insulin action. Bioessays. 23:2001;215-222.
20. Ribon V., Saltiel A.R. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem. J. 324:1997;839-845.
21. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:1994;4902-4911.
22. Tanti J.F., Gremeaux T., Grillo S., Calleja V., Klippe A., Williams L.T., Van Obberghen E., Le Marchand-Brustel Y. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J. Biol. Chem. 271:1996;25227-25232.
23. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell. 3:1974;127-133.
24. Kanzaki M., Pessin J.E. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J. Biol. Chem. 276:2001;42436-42444.
25. Marrero M.B., Schieffer B., Li B., Sun J., Harp J.B., Ling B.N. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 272:1997;24684-24690.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Maestro B., Campion J., Davila N., Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47:2000;383-391.
28. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
29. Matter W.F., Brown R.F., Vlahos C.J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun. 186:1992;624-631.
30. Erlund I., Meririnne E., Alfthan G., Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr. 131:2001;235-241.
31. Rameh L.E., Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:1999;8347-8350.
32. Alessi D.R., Deak M., Casamayor A., Caudwell F.B., Morrice N., Norman D.G., Gaffney P., Reese C.B., MacDougall C.N., Harbison D., Ashworth A., Bownes M. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:1997;776-789.
33. Suga J., Yoshimasa Y., Yamada K., Yamamoto Y., Inoue G., Okamoto M., Hayashi T., Shigemoto M., Kosaki A., Kuzuya H., Nakao K. Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes. 46:1997;735-741.
34. Lin Y.L., Chou C.K. Phosphatidylinositol 3-kinase is required for the regulation of hepatitis B surface antigen production and mitogen-activated protein kinase activation by insulin but not by TPA. Biochem. Biophys. Res. Commun. 246:1998;172-175.
35. Berra E., Diaz-Meco M.T., Lozano J., Frutos S., Municio M.M., Sanchez P., Sanz L., Moscat J. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J. 14:1995;6157-6163.
36. Chou M.M., Blenis J. The 70. kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling Curr. Opin. Cell Biol. 7:1995;806-814.
37. S. Bhagwat, G.R. Beecher, D.B. Haytowitz, J.M. Holden, S. Gebhardt, J. Dwyer, J. Peterson, A. Eldridge, Development of a database for flavonoids in foods, http://www.nal.usda.gov/fnic/foodcomp/Data/Other/NDBC26_Flav.pdf (2002) accessed on 27 March 2003.
38. Arora A., Byrem T.M., Nair M.G., Strasburg G.M. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch. Biochem. Biophys. 373:2000;102-109.